![]() First, I think there will be people for whom vaccine comes to them and people that go to the vaccine. SLAOUI: So, I mean it's may very much depend from one state to the other since, you know, that is the definition exactly, but I would say the following. Give us your expectations for the timing of when different groups will be able to get access and when the general population will be able to, and then what does that vaccination campaign look like I mean, here in New Jersey, I've heard from my county already I'll be getting my vaccine in a Kmart in, you know, the nearby town, it's an empty, you know, big building so what is this going to look like for everybody?ĭR. TIRRELL: What does this start to look like for Americans as more vaccine becomes available. Let's use all the path that's being tested every year and let's enhance it rather than invent something else and I think that's a reasonable approach, minimizes the risk. So, clearly there is a first time and the key assumption we made was let's not invent something that's never been tested. But I think we need to look at the 90% of the story at the same time as we look at 10% or 5% or only 1% of the story. I'm sure I'm sure Meg there will be instances where people were expecting to be vaccinated and, and they had to come the next day or things like that. There is such a level of awareness, such a level of motivation and commitment and resilience in the system that, you know, our expectation and our hope is that it's, it is going to work. I think it is within reason to say that it's an achievable objective. ![]() So here we're talking about double to triple that. 80 million to 100 million vaccine doses distributed and injected in a period of probably five to six months. SLAOUI: So, you know, the benchmark we have frankly is the flu vaccination once a year. Are we actually able, at the last mile level to administer this vaccine to so many people millions of people so quickly?ĭR. I want to ask you about the challenges of this vaccination campaign that we're now embarking upon. TIRRELL: I think one of my favorite videos from the first day we're seeing those healthcare workers in Boston literally dancing in the street at getting these, these vaccines and vaccinations to help really end this pandemic. And I would say on the, on the emotional side of things, seeing people being vaccinated, seeing the emotions that people were expressing and also seeing the recent polls suggesting that there is a much higher or improving acceptance of vaccination in the population, some of them even suggesting 70% or 80% of people now saying they, they would consider taking the vaccine, I think it's very heartwarming and promising for the future so up to now going well. Other, other than that event frankly up to now it's been excellent. You may have heard this morning in our press briefing that there were two pizza boxes as we call them of 975 doses of vaccine that had a temperature excursion downwards, colder than minus 80 Celsius, minus 92, which have been returned and are being assessed within Pfizer to make sure that they're whether they're okay or not. There have been reports of very small damages to the, to the boxes and things like that but not a single vial of vaccine lost or destroyed. Distribution has now taken place to all 636 locations that we have identified and were given to us by the states. SLAOUI: Well, touch wood up to now it's going frankly very well. From what you're observing, how is the rollout going so far?ĭR. TIRRELL: Well, why don't we start with the news this week of course the Pfizer/BioNTech vaccine is going out across the US. Moncef Slaoui, Chief Scientific Adviser to Operation Warp Speed and one of the major reasons we are talking about records being shattered in modern medical history for the speed with which these vaccines or this pandemic have been developed. I'm Meg Tirrell, CNBC's Senior Health and Science Reporter and our guest now is Dr. This, of course, has been the series throughout this year where we've talked with public health experts, researchers, the people who are helping us understand and get through this pandemic. MEG TIRRELL: Welcome back everybody and thanks for sticking with us for this very special Healthy Returns Livestream. Full video will be available at /healthy-returns.Īll references must be sourced to CNBC Healthy Returns Livestream. Moncef Slaoui, Operation Warp Speed Chief Advisor, and CNBC's Senior Health and Science Reporter Meg Tirrell live during the CNBC Healthy Returns Livestream today, Wednesday, December 16th. Following is the unofficial transcript of a CNBC interview with Dr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |